Tumor Metabolism of Malignant Gliomas

Constitutively activated oncogenic signaling via genetic mutations such as in the EGFR/PI3K/Akt and Ras/RAF/MEK pathways has been recognized as a major driver for tumorigenesis in most cancers. Recent insights into tumor metabolism have further revealed that oncogenic signaling pathways directly pro...

Full description

Bibliographic Details
Main Authors: Deliang Guo, Arnab Chakravarti, Terence M. Williams, Peng Ru
Format: Article
Language:English
Published: MDPI AG 2013-11-01
Series:Cancers
Subjects:
Online Access:http://www.mdpi.com/2072-6694/5/4/1469
_version_ 1797713570919612416
author Deliang Guo
Arnab Chakravarti
Terence M. Williams
Peng Ru
author_facet Deliang Guo
Arnab Chakravarti
Terence M. Williams
Peng Ru
author_sort Deliang Guo
collection DOAJ
description Constitutively activated oncogenic signaling via genetic mutations such as in the EGFR/PI3K/Akt and Ras/RAF/MEK pathways has been recognized as a major driver for tumorigenesis in most cancers. Recent insights into tumor metabolism have further revealed that oncogenic signaling pathways directly promote metabolic reprogramming to upregulate biosynthesis of lipids, carbohydrates, protein, DNA and RNA, leading to enhanced growth of human tumors. Therefore, targeting cell metabolism has become a novel direction for drug development in oncology. In malignant gliomas, metabolism pathways of glucose, glutamine and lipid are significantly reprogrammed. Moreover, molecular mechanisms causing these metabolic changes are just starting to be unraveled. In this review, we will summarize recent studies revealing critical gene alterations that lead to metabolic changes in malignant gliomas, and also discuss promising therapeutic strategies via targeting the key players in metabolic regulation.
first_indexed 2024-03-12T07:38:35Z
format Article
id doaj.art-98e17817c45a42bcb76858e08652ef05
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-12T07:38:35Z
publishDate 2013-11-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-98e17817c45a42bcb76858e08652ef052023-09-02T21:25:47ZengMDPI AGCancers2072-66942013-11-01541469148410.3390/cancers5041469Tumor Metabolism of Malignant GliomasDeliang GuoArnab ChakravartiTerence M. WilliamsPeng RuConstitutively activated oncogenic signaling via genetic mutations such as in the EGFR/PI3K/Akt and Ras/RAF/MEK pathways has been recognized as a major driver for tumorigenesis in most cancers. Recent insights into tumor metabolism have further revealed that oncogenic signaling pathways directly promote metabolic reprogramming to upregulate biosynthesis of lipids, carbohydrates, protein, DNA and RNA, leading to enhanced growth of human tumors. Therefore, targeting cell metabolism has become a novel direction for drug development in oncology. In malignant gliomas, metabolism pathways of glucose, glutamine and lipid are significantly reprogrammed. Moreover, molecular mechanisms causing these metabolic changes are just starting to be unraveled. In this review, we will summarize recent studies revealing critical gene alterations that lead to metabolic changes in malignant gliomas, and also discuss promising therapeutic strategies via targeting the key players in metabolic regulation.http://www.mdpi.com/2072-6694/5/4/1469glioblastomatumor metabolismSREBP-1LDLRLXRglucoselipidscholesterol
spellingShingle Deliang Guo
Arnab Chakravarti
Terence M. Williams
Peng Ru
Tumor Metabolism of Malignant Gliomas
Cancers
glioblastoma
tumor metabolism
SREBP-1
LDLR
LXR
glucose
lipids
cholesterol
title Tumor Metabolism of Malignant Gliomas
title_full Tumor Metabolism of Malignant Gliomas
title_fullStr Tumor Metabolism of Malignant Gliomas
title_full_unstemmed Tumor Metabolism of Malignant Gliomas
title_short Tumor Metabolism of Malignant Gliomas
title_sort tumor metabolism of malignant gliomas
topic glioblastoma
tumor metabolism
SREBP-1
LDLR
LXR
glucose
lipids
cholesterol
url http://www.mdpi.com/2072-6694/5/4/1469
work_keys_str_mv AT deliangguo tumormetabolismofmalignantgliomas
AT arnabchakravarti tumormetabolismofmalignantgliomas
AT terencemwilliams tumormetabolismofmalignantgliomas
AT pengru tumormetabolismofmalignantgliomas